Status
Conditions
Treatments
About
The purpose of this study is to collect thermal images of diabetic patients' feet to evaluate the performance of Feetsee - foot monitoring device for periodic evaluation of the temperature over the soles of the feet for signs of inflammation.
Full description
The aim of this study is to collect a database of thermal images of the diabetic persons' feet, and non-diabetic control groups' feet images, which in turn will enable us to build a system based on a mobile thermal camera and a mobile application for possible indication of signs of inflammation in feet. Enrolled participants will undergo a detailed history and physical examination of the foot at the beginning of the procedure day. Then the thermal images of the patient's feet will be taken. Participants will be also asked to take thermal images of their feet according to very well-explained instructions provided by the sponsor. Thermal images using the reference thermal camera will be taken following the Feetsee thermal camera. The images will be unidentified, collected, and stored for the development and performance evaluation of the Feetsee device Algorithm. At the end of the study procedure, participants or their caregivers will receive a short questioner on their experience with using the study device.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion Criteria
Group 1/2: Diabetic with/without ulcers
Male/Female, 18 years or older
Diagnosis of type 1 or type 2 Diabetes Mellitus, confirmed by a family physician or an endocrinologist.
Patient with or without history of previous foot ulcer, confirmed by a family physician or an endocrinologist
For Group 1: Patient with diabetic foot and ulceration diagnosed/confirmed by the study physician on the day of enrollment For Group 2: Patient without ulcers diagnosed/confirmed by the study physician on the day of enrollment
Must be able to read, understand and sign the Informed Consent Form Control: Generally Healthy Non-diabetic
Male/Female, 18 years or older 2. No diabetes mellitus or other diseases that may have signs of polyneuropathy or impaired blood circulation in the foot. 3.No damage to the skin or the soft tissues of the examined feet. 4. Must be able to read, understand and sign the Informed Consent Form
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
112 participants in 3 patient groups
Loading...
Central trial contact
Helena Grinberg, PhD; Linas Liekis, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal